Keros Therapeutics rises after upsized stock offering

Keros Therapeutics

04/01/2024 14:19

**  Keros Therapeutics Inc's  KROS.O  stock up 6.4% at
$43.90 after co raises more equity than targeted
    ** Co late Weds sold 3.5 mln shares at $40 for $140 mln
raise
    ** Offering size boosted from $120 mln
    ** Shares on Weds closed down 4.3% at $41.26
    ** Early Weds, co announced Phase I trials for its new
obesity drug candidate, KER-065, and provided update on its
other pipeline candidates
    ** Co has ~29.96 mln shares outstanding for $1.2 bln market
cap
    ** Shares lost 17% in 2023
    ** Goldman Sachs, Leerink Partners, Piper Sandler and Truist
Securities acting as jt bookrunners for stock offering

 (Lance Tupper is a Reuters market analyst. The views expressed
are his own)
 ((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-646-279-6380))